(Q42212856)

18 October 2017

title

Hologram quantitative structure activity relationship, docking, and molecular dynamics studies of inhibitors for CXCR4. (English)

1 reference

18 October 2017

5

1 reference

18 October 2017

Chongqian Zhang

1

1 reference

18 October 2017

Chunmiao Du

series ordinal

2

1 reference

18 October 2017

Zhiwei Feng

series ordinal

3

1 reference

18 October 2017

Jingyu Zhu

series ordinal

4

1 reference

18 October 2017

publication date

10 July 2014

1 reference

Chemical Biology and Drug Design

18 October 2017

published in

1 reference

18 October 2017

volume

85

1 reference

18 October 2017

issue

2

1 reference

18 October 2017

page(s)

119-136

1 reference

Novel therapies based on mechanisms of HIV-1 cell entry.

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

New developments in HIV drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

HIV entry inhibitors: mechanisms of action and resistance pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

The entry of entry inhibitors: a fusion of science and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Broad HIV-1 neutralization mediated by CD4-binding site antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Crystal structure of the ligand-free G-protein-coupled receptor opsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Crystal structure of squid rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Crystal structure of the β2 adrenergic receptor-Gs protein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Structure of the first sphingosine 1-phosphate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/CXCR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Insight into the structural requirements of narlaprevir-type inhibitors of NS3/NS4A protease based on HQSAR and molecular field analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

All-atom empirical potential for molecular modeling and dynamics studies of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

VEGA – An open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Novel monocyclam derivatives as HIV entry inhibitors: Design, synthesis, anti-HIV evaluation, and their interaction with the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Small molecules anti-HIV therapeutics targeting CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

Studies on the Interactions between β2 Adrenergic Receptor and Gs Protein by Molecular Dynamics Simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12377

NAMD: a Parallel, Object-Oriented Molecular Dynamics Program

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1177/109434209601000401

22 October 2022

Identifiers

DOI

10.1111/CBDD.12377

1 reference

18 October 2017

1 reference